BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, Wang X, Lyu Y, Chen X, Liu K, Yu AM, Zuo Z, Bi H. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B 2019;9:1113-44. [PMID: 31867160 DOI: 10.1016/j.apsb.2019.10.001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 19.3] [Reference Citation Analysis]
Number Citing Articles
1 Alshammari FOFO, Al-Saraireh YM, Youssef AMM, Al-Sarayra YM, Alrawashdeh HM. Cytochrome P450 1B1 Overexpression in Cervical Cancers: Cross-sectional Study. Interact J Med Res 2021;10:e31150. [PMID: 34636736 DOI: 10.2196/31150] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wei Y, Kong L, Chen H, Liu Y, Xu Y, Wang H, Fang G, Shao X, Liu F, Wang Y, Chen Q. Super-resolution image-based tracking of drug distribution in mitochondria of a label-free naturally derived drug molecules. Chemical Engineering Journal 2022;429:132134. [DOI: 10.1016/j.cej.2021.132134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
3 Li R, Zhou S, Gan Z, Wang L, Yu Y. The Biological Fate of a Novel Anticancer Drug Candidate TNBG-5602: Metabolic Profile, Interaction with CYP450, and Pharmacokinetics in Rats. Molecules 2022;27:2594. [PMID: 35458793 DOI: 10.3390/molecules27082594] [Reference Citation Analysis]
4 Lu J, Chen A, Ma X, Shang X, Zhang Y, Guo Y, Liu M, Wang X. Generation and Characterization of Cytochrome P450 2J3/10 CRISPR/Cas9 Knockout Rat Model. Drug Metab Dispos 2020;48:1129-36. [DOI: 10.1124/dmd.120.000114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Li C, Li J, Lai J, Liu Y. The pharmacological and pharmacokinetic properties of esculin: A comprehensive review. Phytotherapy Research. [DOI: 10.1002/ptr.7470] [Reference Citation Analysis]
6 Pokhrel S, Bouback TA, Samad A, Nur SM, Alam R, Abdullah-Al-Mamun M, Nain Z, Imon RR, Talukder MEK, Tareq MMI, Hossen MS, Karpiński TM, Ahammad F, Qadri I, Rahman MS. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2. Int J Biol Macromol 2021;191:1114-25. [PMID: 34592225 DOI: 10.1016/j.ijbiomac.2021.09.146] [Reference Citation Analysis]
7 Wang Z, Zhang Z, Li Y, Sun L, Peng D, Du D, Zhang X, Han L, Zhao L, Lu L, Du H, Yuan S, Zhan M. Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China. Acta Pharm Sin B 2021;11:1526-40. [PMID: 34221866 DOI: 10.1016/j.apsb.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fuchigami H, Bal MK, Brownson DAC, Banks CE, Jones AM. Voltammetric Behaviour of Drug Molecules as a Predictor of Metabolic Liabilities. Sci Pharm 2020;88:46. [DOI: 10.3390/scipharm88040046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Holanda VN, Lima EMA, Silva WVD, Maia RT, Medeiros RL, Ghosh A, Lima VLM, Figueiredo RCBQ. Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study. J Biomol Struct Dyn 2021;:1-19. [PMID: 33459182 DOI: 10.1080/07391102.2020.1871073] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Choi YH, Zhang C, Liu Z, Tu MJ, Yu AX, Yu AM. A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism. J Pharmacol Exp Ther 2021;377:305-15. [PMID: 33712506 DOI: 10.1124/jpet.121.000584] [Reference Citation Analysis]
11 Li J, Xu Z, Gu J. UGT1A1 and UGT1A9 Are Responsible for Phase II Metabolism of Tectorigenin and Irigenin In Vitro. Molecules 2022;27:4104. [DOI: 10.3390/molecules27134104] [Reference Citation Analysis]
12 Li F, Song C, Zhang Y, Wu D. Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs. Acta Biochim Biophys Sin (Shanghai) 2022;54:12-24. [PMID: 35130630 DOI: 10.3724/abbs.2021001] [Reference Citation Analysis]
13 Bergström H, Lindahl A, Warnqvist A, Diczfalusy U, Ekström L, Björkhem-Bergman L. Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β-hydroxycortisol/cortisol. Pharmacol Res Perspect 2021;9:e00884. [PMID: 34664787 DOI: 10.1002/prp2.884] [Reference Citation Analysis]
14 Luo X, She J, Xu T, Zhou Y, Xu C, Jiang J, Li T, Liu H, Shen H, Yin B, Dai B. Establishment and characterization of organoids from a patient with adenomyoepithelioma of the breast. Bioengineered 2021;12:11578-85. [PMID: 34874791 DOI: 10.1080/21655979.2021.1974809] [Reference Citation Analysis]
15 Pan K, Shi X, Liu K, Wang J, Chen Y. Efficacy, Pharmacokinetics, Biodistribution and Excretion of a Novel Acylated Long-Acting Insulin Analogue INS061 in Rats. Drug Des Devel Ther 2021;15:3487-98. [PMID: 34408401 DOI: 10.2147/DDDT.S317327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang H, Brown PC, Chow ECY, Ewart L, Ferguson SS, Fitzpatrick S, Freedman BS, Guo GL, Hedrich W, Heyward S, Hickman J, Isoherranen N, Li AP, Liu Q, Mumenthaler SM, Polli J, Proctor WR, Ribeiro A, Wang JY, Wange RL, Huang SM. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration. Clin Transl Sci 2021. [PMID: 33982436 DOI: 10.1111/cts.13066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Paniri A, Hosseini MM, Rasoulinejad A, Akhavan-Niaki H. Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations. Eur J Pharmacol 2020;886:173454. [PMID: 32763298 DOI: 10.1016/j.ejphar.2020.173454] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
18 Lu D, Zhao M, Chen M, Wu B. Circadian Clock-Controlled Drug Metabolism: Implications for Chronotherapeutics. Drug Metab Dispos 2020;48:395-406. [PMID: 32114506 DOI: 10.1124/dmd.120.090472] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
19 Xie V. Understanding drug-protein binding and ADME studies for DMPK. Bioanalysis 2022. [PMID: 35703337 DOI: 10.4155/bio-2022-0112] [Reference Citation Analysis]
20 Zhang Y, Huang S, Zhong W, Chen W, Yao B, Wang X. 3D organoids derived from the small intestine: An emerging tool for drug transport research. Acta Pharm Sin B 2021;11:1697-707. [PMID: 34386316 DOI: 10.1016/j.apsb.2020.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
21 Perovani IS, Mariano Bucci JL, Carrão DB, Santos Barbetta MF, Moreira da Silva R, Lopes NP, Moraes de Oliveira AR. Enantioselective inhibition of human CYP2C19 by the chiral pesticide ethofumesate: Prediction of pesticide-drug interactions in humans. Chem Biol Interact 2021;345:109552. [PMID: 34147487 DOI: 10.1016/j.cbi.2021.109552] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Negari IP, Keshari S, Huang CM. Probiotic Activity of Staphylococcus epidermidis Induces Collagen Type I Production through FFaR2/p-ERK Signaling. Int J Mol Sci 2021;22:1414. [PMID: 33572500 DOI: 10.3390/ijms22031414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Auxtero MD, Chalante S, Abade MR, Jorge R, Fernandes AI. Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction. Pharmaceutics 2021;13:124. [PMID: 33478035 DOI: 10.3390/pharmaceutics13010124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
24 Mak KK, Epemolu O, Pichika MR. The role of DMPK science in improving pharmaceutical research and development efficiency. Drug Discov Today 2021:S1359-6446(21)00484-0. [PMID: 34774767 DOI: 10.1016/j.drudis.2021.11.005] [Reference Citation Analysis]
25 Tedeschi LO, Muir JP, Naumann HD, Norris AB, Ramírez-Restrepo CA, Mertens-Talcott SU. Nutritional Aspects of Ecologically Relevant Phytochemicals in Ruminant Production. Front Vet Sci 2021;8:628445. [PMID: 33748210 DOI: 10.3389/fvets.2021.628445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
26 Luo Y, Zhou T. Connecting the dots: Targeting the microbiome in drug toxicity. Med Res Rev 2021. [PMID: 33856076 DOI: 10.1002/med.21805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Paudel S, Kim Y, Choi SM, Kim JH, Bae JS, Lee T, Lee S. Identification of suberosin metabolites in human liver microsomes by high-performance liquid chromatography combined with high-resolution quadrupole-orbitrap mass spectrometer. J Mass Spectrom 2021;56:e4623. [PMID: 32734675 DOI: 10.1002/jms.4623] [Reference Citation Analysis]
28 Zhai K, Duan H, Wang W, Zhao S, Khan GJ, Wang M, Zhang Y, Thakur K, Fang X, Wu C, Xiao J, Wei Z. Ginsenoside Rg1 ameliorates blood-brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release. Acta Pharm Sin B 2021;11:3493-507. [PMID: 34900532 DOI: 10.1016/j.apsb.2021.03.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
29 Lai Y, Chu X, Di L, Gao W, Guo Y, Liu X, Lu C, Mao J, Shen H, Tang H, Xia CQ, Zhang L, Ding X. Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. Acta Pharmaceutica Sinica B 2022;12:2751-77. [DOI: 10.1016/j.apsb.2022.03.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Jiang Y, Yao X, Fan S, Gao Y, Zhang H, Huang M, Bi H. Lipidomic profiling reveals triacylglycerol accumulation in the liver during pregnane X receptor activation-induced hepatomegaly. J Pharm Biomed Anal 2021;195:113851. [PMID: 33387840 DOI: 10.1016/j.jpba.2020.113851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Chen B, Luo H, Chen W, Huang Q, Zheng K, Xu D, Li S, Liu A, Huang L, Zheng Y, Lin X, Yao H. Pharmacokinetics, Tissue Distribution, and Human Serum Albumin Binding Properties of Delicaflavone, a Novel Anti-Tumor Candidate. Front Pharmacol 2021;12:761884. [PMID: 34867382 DOI: 10.3389/fphar.2021.761884] [Reference Citation Analysis]
32 Kaboudi N, Alizadeh AA, Shayanfar A. In silico models to predict tubular secretion or reabsorption clearance pathway using physicochemical properties and structural characteristics. Xenobiotica 2022;:1-16. [PMID: 35543185 DOI: 10.1080/00498254.2022.2076632] [Reference Citation Analysis]
33 Bellagambi FG, Lomonaco T, Ghimenti S, Biagini D, Fuoco R, Di Francesco F. Determination of peppermint compounds in breath by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry. J Breath Res 2020. [PMID: 33238253 DOI: 10.1088/1752-7163/abcdec] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Lu J, Liu J, Guo Y, Zhang Y, Xu Y, Wang X. CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics. Acta Pharm Sin B 2021;11:2973-82. [PMID: 34745851 DOI: 10.1016/j.apsb.2021.01.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
35 F. Martins ML, Heydari P, Li W, Martínez-chávez A, Venekamp N, Lebre MC, Lucas L, Beijnen JH, Schinkel AH. Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites. Front Pharmacol 2022;13:855000. [DOI: 10.3389/fphar.2022.855000] [Reference Citation Analysis]
36 Fernández-Ballester G, Fernández-Carvajal A, Ferrer-Montiel A. Targeting thermoTRP ion channels: in silico preclinical approaches and opportunities. Expert Opin Ther Targets 2020;24:1079-97. [PMID: 32972264 DOI: 10.1080/14728222.2020.1820987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Rilstone V, Vignale L, Craddock J, Cushing A, Filion Y, Champagne P. The role of antibiotics and heavy metals on the development, promotion, and dissemination of antimicrobial resistance in drinking water biofilms. Chemosphere 2021;282:131048. [PMID: 34470147 DOI: 10.1016/j.chemosphere.2021.131048] [Reference Citation Analysis]
38 Xu H, Zhang Y, Wang P, Zhang J, Chen H, Zhang L, Du X, Zhao C, Wu D, Liu F, Yang H, Liu C. A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine. Acta Pharm Sin B 2021;11:1379-99. [PMID: 34221858 DOI: 10.1016/j.apsb.2021.03.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
39 Fan X, Bai J, Hu M, Xu Y, Zhao S, Sun Y, Wang B, Hu J, Li Y. Drug interaction study of flavonoids toward OATP1B1 and their 3D structure activity relationship analysis for predicting hepatoprotective effects. Toxicology 2020;437:152445. [PMID: 32259555 DOI: 10.1016/j.tox.2020.152445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kong L, Chen J, Ji X, Qin Q, Yang H, Liu D, Li D, Sun M. Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance. J Exp Clin Cancer Res 2021;40:18. [PMID: 33413501 DOI: 10.1186/s13046-020-01782-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Mohammed HO, Almási A, Molnár S, Perjési P. The Intestinal and Biliary Metabolites of Ibuprofen in the Rat with Experimental Hyperglycemia. Molecules 2022;27:4000. [DOI: 10.3390/molecules27134000] [Reference Citation Analysis]
42 Liu KH, Lee CM, Singer G, Bais P, Castellanos F, Woodworth MH, Ziegler TR, Kraft CS, Miller GW, Li S, Go YM, Morgan ET, Jones DP. Large scale enzyme based xenobiotic identification for exposomics. Nat Commun 2021;12:5418. [PMID: 34521839 DOI: 10.1038/s41467-021-25698-x] [Reference Citation Analysis]
43 Al-Hamadani MYI, Alzahrani AM, Yousef MI, Kamel MA, El-Sayed WM. Gold Nanoparticles Perturb Drug-Metabolizing Enzymes and Antioxidants in the Livers of Male Rats: Potential Impact on Drug Interactions. Int J Nanomedicine 2020;15:5005-16. [PMID: 32764932 DOI: 10.2147/IJN.S248194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 F Martins ML, Loos NHC, Mucuk S, de Jong D, Lebre MC, Rosing H, Tibben M, Beijnen JH, Schinkel AH. P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib. Mol Pharm 2021;18:4371-84. [PMID: 34730366 DOI: 10.1021/acs.molpharmaceut.1c00553] [Reference Citation Analysis]
45 Bagheri S, Saboury AA. Hypothesis of using albumin to improve drug efficacy in cancers accompanied by hypoalbuminemia. Xenobiotica 2021;51:778-85. [PMID: 33979263 DOI: 10.1080/00498254.2021.1929557] [Reference Citation Analysis]
46 Das T, Anand U, Pandey SK, Ashby CR Jr, Assaraf YG, Chen ZS, Dey A. Therapeutic strategies to overcome taxane resistance in cancer. Drug Resist Updat 2021;55:100754. [PMID: 33691261 DOI: 10.1016/j.drup.2021.100754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
47 Alghamdi MA, Fallica AN, Virzì N, Kesharwani P, Pittalà V, Greish K. The Promise of Nanotechnology in Personalized Medicine. JPM 2022;12:673. [DOI: 10.3390/jpm12050673] [Reference Citation Analysis]
48 Zdesenko G, Mutapi F. Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models. PLoS Negl Trop Dis 2020;14:e0008649. [PMID: 32976496 DOI: 10.1371/journal.pntd.0008649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
49 Khalil AS, Jaenisch R, Mooney DJ. Engineered tissues and strategies to overcome challenges in drug development. Adv Drug Deliv Rev 2020;158:116-39. [PMID: 32987094 DOI: 10.1016/j.addr.2020.09.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
50 Sun D, Lu J, Zhang Y, Liu J, Liu Z, Yao B, Guo Y, Wang X. Characterization of a Novel CYP1A2 Knockout Rat Model Constructed by CRISPR/Cas9. Drug Metab Dispos 2021;49:638-47. [PMID: 34074728 DOI: 10.1124/dmd.121.000403] [Reference Citation Analysis]